Welcome to San Francisco Biotech Networks DAILY for 01/11/2026. Daily news and jobs are listed below. Please forward this email to your colleagues so they can subscribe at biotechnetworks.org/daily

​​​​​​​

Click a link below to view the mailing archive as if it had been sent to you.

2022-02-26 01:30New simulations refine axion mass, refocusing dark matter search and more...
2022-02-25 01:30Accuray to Participate in the Cowen 42nd Annual Health Care Conference and more...
2022-02-24 01:30Nevro Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides First Quarter and Full-Year 2022 Guidance and more...
2022-02-23 01:3010x Genomics Showcases Robust Innovation Pipeline at Xperience 2022 Event and more...
2022-02-22 01:30Four early-career scholars named Sloan Research Fellows and more...
2022-02-21 01:30Bristol Myers gets FDA decision date for earlier use of CAR-T therapy and more...
2022-02-19 01:30Getting to the Heart of Complex Disease and more...
2022-02-18 01:30PolyActiva Announces Positive Phase IIa Trial Results in Low Dose Cohort for PA5108 Ocular Implant with Prezia™ Sustained Drug Delivery Technology and more...
2022-02-17 01:30Innovent Announces Two Registration Studies of IBI306 (anti-PCSK-9 antibody) Met Primary Endpoint and more...
2022-02-16 01:30Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares and more...
2022-02-15 01:30Janssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus Prednisone Significantly Improved Radiographic Progression-Free Survival as a First-Line Therapy in Patients with HRR Gene-Mutated Metastatic ...
2022-02-14 01:30U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by Innovent and IASO Bio and more...
2022-02-12 01:30Phase 2/3 Interim Data Evaluating the Safety, Tolerability and Clinical Outcomes of Veklury® (Remdesivir) in Pediatric Patients With COVID-19 Presented at CROI 2022 and more...
2022-02-11 01:30FDA Advisory Committee Votes to Recommend Additional Data for Sintilimab Submission and more...
2022-02-10 01:30Aurora Technology Acquisition Corp. Announces Closing of $202 Million Initial Public Offering, Including Exercise of the Underwriters' Over-Allotment Option and more...
2022-02-09 01:30Veracyte to Participate in 11th Annual SVB Leerink Global Healthcare Conference and more...
2022-02-08 01:30First-to-Market Vendor Management Application for Pharma R&D and more...
2022-02-05 01:30Scientists Reveal "Rosetta Stone" of Immune Cell Function and more...
2022-02-04 01:30Anti-aging company Unity Biotechnology to axe half its staff, focus on eye drugs and more...
2022-02-03 01:30Part of Gilead's big cancer deal boom two years ago, this drug now brings questions and more...
2022-02-02 01:30After Alzheimer's drug flop, Peninsula biotech's founding execs exit and more...
2022-02-01 01:30Genentech wins FDA approval of drug to treat two blinding eye diseases and more...

 

<< Archive Index • Subscribe >>

 

© Biotech Networks. You're receiving this email because you've signed up to receive updates from us.

If you'd prefer not to receive updates, you can unsubscribe.
 
© FeedBlitz® - Win the Inbox ™ | feedblitz.com | info@feedblitz.com | Privacy | Terms of Service
 English | Português | Français | Español | Italiano | Nederlands | Svenska | Deutsch | 日本語